According to the decision, they did not since Myriad did not submit for that. From the ruling:
First, there are no method claims before this Court. Had Myriad created an innovative method of manipulating genes while searching for the BRCA1 and BRCA2 genes, it could possibly have sought a method pat- ent. But the processes used by Myriad to isolate DNAwere well understood by geneticists at the time of Myriad’s patents “were well understood, widely used, and fairlyuniform insofar as any scientist engaged in the search fora gene would likely have utilized a similar approach,” 702 F. Supp. 2d, at 202–203, and are not at issue in this case.
Still, he could have gotten a patent for a process ~ but the USSC isn’t about to give somebody else on the very same genes they got in their bodies ~